NICE and NHS England leads the way to improve diabetes care with access to continuous glucose monitoring for people with type 1 diabetes.

These new recommendations from NICE 2022 represent a significant shift in providing universal health coverage and access to CGM for all people with type 1 diabetes and were adopted by NHS England as a commissioning body for the NHS. Keywords: Continuous glucose monitoring; Type 1 diabetes; NICE, Diabetes technology EN Continuous glucose monitoring Type 1 diabetes NICE, Diabetes technology 1 3 3 08/10/23 20230808 NES 230808 Background Type 1 diabetes care (T1D) management is complex and there is clear evidence that access to diabetes technologies has the potential to improve glycaemic management, quality of life and to prevent long-term diabetes complications. [Extracted from the article]

Copyright of BMC Medicine is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)